Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dosecam ketamine with dexmedetomidine vs Dosecam ketamine with propofol in cataract surgery
IRCT20160307026950N43Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cataract and hypotension comparing Dosecam ketamine + dexmedetomidine with Dosecam ketamine + propofol (2 arms). Primary endpoints: Change in heart rate and Change in blood pressure. Started Aug 2022; status: completed.
02
Drugs
ketaminedexmedetomidinepropofol
03
Conditions
cataracthypotension
Beyond the preview
Go deeper on IRCT20160307026950N43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N43.